Development of a risk-priority score for category A bioterrorism agents as an aid for public health policy

Military Medicine

Volumn 171, Issue 7, 2006, Pages 589-594

  MacIntyre, C Raina ^a   Seccull, Alison ^b   Lane, J Michael ^b   Plant, Alleen ^c  

^a UNIVERSITY OF SYDNEY   (Australia)

^b Department of Human Services ^*  (United States)

^c CURTIN UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRAX; ARTICLE; BIOLOGICAL WARFARE; HEALTH CARE PLANNING; HEALTH CARE POLICY; RISK ASSESSMENT; SMALLPOX; SOLDIER; TULAREMIA; VACCINATION;

EID: 33745950444     PISSN: 00264075     EISSN: None     Source Type: Journal    
DOI: 10.7205/MILMED.171.7.589     Document Type: Article

References (41)

1. Robertson A, Robertson L: From Asps to allegations: biological warfare in history. Milit Med 1995; 160: 369.
2. Malloy C: A history of biological and chemical warfare and terrorism. J Public Health Manag Pract 2000; 6: 30-7.
3. Inglesby T, OToole T, Henderson DA, et al: Anthrax as a biological weapon: 2002 updated recommendations for management. JAMA 2002; 287: 2236-52.
4. Cieslak TJ, Edward M, Eitzen J: Clinical and epidemiologic principles of anthrax. Emerg Infect Dis 1999; 5.
5. Anderson RM, May MM: Infectious Diseases of Humans. Dynamics and Control, p 757. London, U.K., Oxford University Press. 1999.
6. Meltzer MI, Damon I, LeDuc JW, Millar JD: Modeling potential responses to smallpox as a bioterrorist weapon. Emerg Infect Dis 2001; 7: 959-69.
7. Legrand J, Viboud C, Boelle PY, Valleron AJ, Flahault A: Modelling responses to a smallpox epidemic taking into account uncertainty. Epidemiol Infect 2004; 132: 19-25.
8. Bozzette SA, Boer R, Bhatnagar V, et al: A model for a smallpox-vaccination policy. N Engl J Med 2003; 348: 416-25.
9. Gani R, Leach S: Transmission potential of smallpox in contemporary populations. Nature 2001; 414: 748-51.
10. Eichner M, Dietz K: Transmission potential of smallpox: estimates based on detailed data from an outbreak. Am J Epidemiol 2003; 158: 110-7.
11. Inglesby T, Dennis DT, Henderson DA, et al: Plague as a biological weapon medical and public health management. JAMA 2000; 283: 2281-90.
12. Anonymous: Use of anthrax vaccine in response to terrorism: supplemental recommendations of the Advisory Committee on Immunization Practices. MMWR Morb Mortal Wkly Rep 2002; 51: 1024-6.
13. Meselson M, Guillemin J, Hugh-Jones M, et al: The Sverdlovsk anthrax outbreak of 1979. Science 1994; 266: 1202-8.
14. Jefferson T, Demicheli V, Deeks J, Graves P, Pratt M, Rivetti D: Vaccines for preventing anthrax. Cochrane Database Syst Rev 2000; CD000975.
15. Henderson DA, Inglesby TV, Bartlett JG, et al: Smallpox as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. JAMA 1999; 281: 2127-37.
16. Henderson DA: Bioterrorism as a public health threat. Emerg Infect Dis 1998; 4: 488-92.
17. Shapiro RL, Hatheway C, Swerdlow DL: Botulism in the United States: a clinical and epidemiologic review. Ann Intern Med 1998; 129: 221-8.
18. CDC. Fatal human plague - Arizona and Colorado, 1996. MMWR Morb Mortal Wkly Rep 1997; 46: 617-20.
19. Dennis DT, Inglesby TV, Henderson DA, et al: Tularemia as a biological weapon: medical and public health management. JAMA 2001; 285: 2763-73.
20. Anonymous. Viral Hemorrhagic Fever (VHF) Medical Summary. Alexandria, VA, Infectious Disease Society of America. 2003.
21. Infectious Disease Society of America. Botulism Medical Summary, Vol. 2003, Alexandria, VA, Infectious Disease Society of America. 2003. Available at http:// www.idsociety.org/Template.cfm?Section=Bioterrorism&Template=/ TaggedPage/ TaggedPageDisplay.cfm&TPLID=27&ContentID=5022; accessed January 16, 2004.
22. Infectious Disease Society of America. Plague Medical Summary, Vol. 2003, Alexandria, VA, Infectious Disease Society of America. 2003. Available at http:// www.idsociety.org/Template.cfm?Section=Bioterrorism&Template=/ TaggedPage/ TaggedPageDisplay.cfm&TPLID=27&ContentID=5022; Accessed January 16, 2004.
23. HPA-Colindale: Interim Guidelines for Action in the Event of a Deliberate Release. Plague Version 5.2. London, U.K., HPA-Colindale, 2003.
24. Burrows WD, Renner SE: Biological warfare agents as threats to potable water. Environ Health Perspect 1999; 107: 975-85.
25. Working Group on Civilian Biodefense. Hemorrhagic fever viruses as biological weapons medical and public health management. JAMA 2002; 287: 2391-405.
26. Meselson M, Guillemin J, Hugh-Jones M, et al: The Sverdlovsk anthrax outbreak of 1979. Science 1994; 266; 1202-7.
27. Inglesby T, Henderson D, Bartlett J, et al: Anthrax as a biological weapon, medical and public health management. JAMA 1999; 281: 1735-45.
28. Henderson DA: The looming threat of bioterrorism. Science 1999; 283: 1279-82.
29. Weinstein RS, Alibek K. Biological and Chemical Terrorism: A Guide for Healthcare Providers and First Respondent. New York. Thieme, 2003.
30. Working Group on Civilian Biodefense. 1. Botulinum toxin as a biological weapon: medical and public health management. 2. Botulinum toxin as a biological weapon (Addendum). Vol 2003. Baltimore. MD, National Guideline Clearing-house. 2001.
31. Centres for Disease Control and Prevention. Botulism in the United States. 1899-1996. In: Handbook for Epidemiologists. Clinicians and Laboratory Workers. Atlanta. GA. Centers for Disease Control. 1998.
32. Dennis DT, Inglesby TV, Henderson DA, et al: Tularemia as a biological weapon medical and public health management. JAMA 2001; 285: 2763-73.
33. ProMed mail. Outbreak of Ebola hemorrhagic fever-Uganda, August 2000-January 2001. MMWR Morbidity and Mortality Weekly Report. 2001; 50: 73-7.
34. Arora N: Site directed mutagenesis of histidine residues in anthrax toxin lethal factor binding domain reduces toxicity. Mol Cell Biochem 1997; 177: 7-14.
35. Alibek K, Handelman S, Biohazard. New York, NY, Random House, 1998.
36. Finkel E: Australia: Engineered mouse virus spurs bioweapon fears. Science 2001; 291: 585.
37. Kadlec RP, Zellicoff AP, Vrtis AM: Biological weapons control prospects and implications for the future. JAMA 1997; 278: 351-6.
38. Lauriano CM, Barker JR, Nano FE, Arulanandam BP, Klose KE: Allelic exchange in Francisella tularensis using PCR products. FEMS Microbiol Lett 2003; 229: 195-202.
39. Alibek K: Biohazard. London, UK, Arrow Books, 1999.
40. Bronze MS, Huycke MM, Machado LJ, Voskuhl GW, Greenfield RA: Viral agents as biological weapons and agents of bioterrorism. Am J Med Sci 2002; 323: 316-25.
41. Sinha G: Uncertain threat: Does smallpox really spread that easily? Sci Am 2004; 290: 18, 20.